Skip to main content
Caplight Logo









Emblok

Emblok

Private
Grand Rapids, MichiganHealthcare & Life Scienceshttps://emblok.com/

Last Round

Seed Round

Jun 18, 2026

Total Funding Raised

$18M

Momentum

Top 25%

of companies Caplight tracks

Company Overview

Emblok is a surgical devices company that has developed a whole-body embolic protection system designed to offer protection from material released during left-sided cardiovascular procedures.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Clinical Trials

Business Model

B2B

Customer Profile

Hardware Sales

AI Layer

Non-AI

Keywords

embolic protection systemTAVRembolic protectionwhole-body embolic protectionstroke preventionstructural heart devicetranscatheter aortic valve replacementinterventional cardiologycatheter-based devicemedtechclinical-stage companyaortic valve stenosis

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Emblok Comparables

Compare Emblok with similar companies based on industry and business-model similarity.

Emblok comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Emboline
94%
EmStop, Inc.
92%
Filterlex Medical
92%

Emblok Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Seed RoundJun 18, 2026
Series CDec 18, 2018
Series BJul 11, 2017
Series ANov 27, 2014

Key People

Founding team and executive leadership

Bradley Brown

President and CEO

Executive Team

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jun 18, 2026

    Raised $6M in seed funding.

  • Apr 18, 2026

    Monthly visitors grew 81% MoM, reaching 288.

Recent news

Latest coverage and updates

  • receives_financingJul 9, 2026

    Emblok received financing of $6M in development capital on Jun 1st '26.

Emblok Filings

Explore SEC and related filing metadata, where available.

Emblok filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Emblok's valuation, stock price, and market status.

Is Emblok a public or private company?

Emblok is a private company.

What is the current stock price of Emblok?

Emblok is a private company with no public stock price. No recent secondary market data is available.

How much is Emblok worth (valuation)?

Valuation information for Emblok is not publicly available.

Can I buy Emblok stock?

Emblok shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Emblok's last funding round?

Emblok's most recent funding round was Seed Round on June 18, 2026.

Who are the main investors in Emblok?

Investor information for Emblok is not publicly disclosed.

Will Emblok IPO soon?

No public IPO plans have been announced for Emblok.

How can I track Emblok secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Emblok's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersGrand Rapids, Michigan
Employee Range8
Year Founded2012
Last FundingJun 18, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?